Finance

Lists
543245:BOM
Gland Pharma Ltd
3 060,00 INR
+0,09%
(+2,70) 1D
16 ოქტ, 09:16:20 GMT+5:30  ·   INR
All symbols
SymbolPriceChange% Change
Generating top insights for 543245...
Open
3 057,30 INR
High
3 061,25 INR
Low
3 043,00 INR
Mkt. cap
503,42 მლრ.
Avg. vol.
434,88 ათ.
Volume
127,00
Dividend
0,65%
Quarterly dividend
5,00 INR
Ex-dividend date
11 აგვ. 2026
P/E ratio
44,75
52-wk high
3 171,00 INR
52-wk low
1 575,00 INR
EPS
68,39 INR
No. of employees
4 ათ.
Open
3 057,30 INR
High
3 061,25 INR
Low
3 043,00 INR
Mkt. cap
503,42 მლრ.
Avg. vol.
434,88 ათ.
Volume
127,00
Dividend
0,65%
Quarterly dividend
5,00 INR
Ex-dividend date
11 აგვ. 2026
P/E ratio
44,75
52-wk high
3 171,00 INR
52-wk low
1 575,00 INR
EPS
68,39 INR
No. of employees
4 ათ.
News stories
From web sources and news partners
Simply Wall Street
Simply Wall Street
·
1 საათის წინ
What Dropbox Holders Bought Into
Investor's Business Daily
Investor's Business Daily
·
35 წუთის წინ
Futures Mixed; Anthropic Value, Tesla Roadster In Focus
About Gland Pharma Ltd
CEOShyamakant Giri
Employees4,33 ათ.
Founded1978
Headquarters-
SectorPharmaceutical industry
Previous reportsAll values in INR
Loading Previous Earnings...
Revenue
Net income
All values in INR
სექ. 2025
დეკ. 2025
მარ. 2026
ივნ. 2026
Revenue
14,87 მლრდ.
16,95 მლრდ.
17,43 მლრდ.
18,00 მლრდ.
Cost of goods sold
6,04 მლრდ.
6,31 მლრდ.
8,32 მლრდ.
6,80 მლრდ.
Cost of revenue
6,04 მლრდ.
6,31 მლრდ.
8,32 მლრდ.
6,80 მლრდ.
Research and development expenses
-
-
-
-
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
3,85 მლრდ.
4,24 მლრდ.
4,26 მლრდ.
4,44 მლრდ.
Operating expense
6,75 მლრდ.
7,37 მლრდ.
5,22 მლრდ.
7,42 მლრდ.
Total operating expenses
12,79 მლრდ.
13,68 მლრდ.
13,54 მლრდ.
14,22 მლრდ.
Operating income
2,08 მლრდ.
3,27 მლრდ.
3,89 მლრდ.
3,78 მლრდ.
Other non operating income
841,62 მლნ.
631,73 მლნ.
-1,79 მლრდ.
612,28 მლნ.
EBT including unusual items
2,84 მლრდ.
3,62 მლრდ.
5,06 მლრდ.
4,35 მლრდ.
EBT excluding unusual items
2,84 მლრდ.
3,86 მლრდ.
5,02 მლრდ.
4,35 მლრდ.
Income tax expense
1,00 მლრდ.
1,01 მლრდ.
1,39 მლრდ.
1,18 მლრდ.
Effective tax rate
35,30%
27,79%
27,51%
27,13%
Other operating expenses
1,84 მლრდ.
2,06 მლრდ.
-130,22 მლნ.
1,87 მლრდ.
Net income
1,84 მლრდ.
2,61 მლრდ.
3,67 მლრდ.
3,17 მლრდ.
Net profit margin
12,35%
15,42%
21,04%
17,61%
Earnings per share
11,15
16,98
22,23
19,22
Interest and investment income
-
-
2,06 მლრდ.
-
Interest expense
-78,23 მლნ.
-39,30 მლნ.
-63,09 მლნ.
-43,61 მლნ.
Net interest expenses
-78,23 მლნ.
-39,30 მლნ.
1,99 მლრდ.
-43,61 მლნ.
Depreciation and amortization charges
1,06 მლრდ.
1,08 მლრდ.
1,09 მლრდ.
1,11 მლრდ.
EBITDA
3,11 მლრდ.
4,17 მლრდ.
4,91 მლრდ.
4,80 მლრდ.
Gain or loss from assets sale
-
-
-
-
AI content may include mistakes. Learn more
Google აპები